76 related articles for article (PubMed ID: 28165652)
1. Candidate susceptibility variants for esophageal squamous cell carcinoma.
Donner I; Katainen R; Tanskanen T; Kaasinen E; Aavikko M; Ovaska K; Artama M; Pukkala E; Aaltonen LA
Genes Chromosomes Cancer; 2017 Jun; 56(6):453-459. PubMed ID: 28165652
[TBL] [Abstract][Full Text] [Related]
2. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Ko JM; Ning L; Zhao XK; Chai AWY; Lei LC; Choi SSA; Tao L; Law S; Kwong A; Lee NP; Chan KT; Lo A; Song X; Chen PN; Chang YL; Wang LD; Lung ML
Int J Cancer; 2020 Feb; 146(4):1042-1051. PubMed ID: 31396961
[TBL] [Abstract][Full Text] [Related]
3. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
4. Contribution of germ line BRCA2 sequence alterations to risk of familial esophageal cancer in a high-risk area of India.
Kaushal M; Chattopadhyay I; Phukan R; Purkayastha J; Mahanta J; Kapur S; Saxena S
Dis Esophagus; 2010 Jan; 23(1):71-5. PubMed ID: 19473207
[TBL] [Abstract][Full Text] [Related]
5. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.
Akbari MR; Malekzadeh R; Nasrollahzadeh D; Amanian D; Islami F; Li S; Zandvakili I; Shakeri R; Sotoudeh M; Aghcheli K; Salahi R; Pourshams A; Semnani S; Boffetta P; Dawsey SM; Ghadirian P; Narod SA
Oncogene; 2008 Feb; 27(9):1290-6. PubMed ID: 17724471
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer.
Hu N; Wang C; Han XY; He LJ; Tang ZZ; Giffen C; Emmert-Buck MR; Goldstein AM; Taylor PR
Oncogene; 2004 Jan; 23(3):852-8. PubMed ID: 14647438
[TBL] [Abstract][Full Text] [Related]
7. Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population.
Cui XB; Chen YZ; Pang XL; Liu W; Hu JM; Li SG; Yang L; Zhang WJ; Liu CX; Cao YW; Jiang JF; Gu WY; Pang J; Yang L; Yuan XL; Yu SY; Li F
Gene; 2013 Nov; 530(2):315-22. PubMed ID: 23981775
[TBL] [Abstract][Full Text] [Related]
8. ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma.
Sun Y; Shi N; Lu H; Zhang J; Ma Y; Qiao Y; Mao Y; Jia K; Han L; Liu F; Li H; Lin Z; Li X; Zhao X
Carcinogenesis; 2014 Sep; 35(9):1941-50. PubMed ID: 24510239
[TBL] [Abstract][Full Text] [Related]
9. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
[TBL] [Abstract][Full Text] [Related]
10. Functional SNPs in human C20orf54 gene influence susceptibility to esophageal squamous cell carcinoma.
Ji A; Wang J; Yang J; Wei Z; Lian C; Ma L; Ma L; Chen J; Qin X; Wang Ld; Wei W
Asian Pac J Cancer Prev; 2011; 12(12):3207-12. PubMed ID: 22471455
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing of familial esophageal squamous cell carcinoma identified rare pathogenic variants in new predisposition genes.
Golyan FF; Druley TE; Abbaszadegan MR
Clin Transl Oncol; 2020 May; 22(5):681-693. PubMed ID: 31321674
[TBL] [Abstract][Full Text] [Related]
12. Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
Lacerda CF; Cruvinel-Carloni A; de Oliveira AT; Scapulatempo-Neto C; López RV; Crema E; Adad SJ; Rodrigues MA; Henry MA; Guimarães DP; Reis RM
Dis Esophagus; 2017 Apr; 30(4):1-9. PubMed ID: 28375484
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer.
Saarinen S; Vahteristo P; Lehtonen R; Aittomäki K; Launonen V; Kiviluoto T; Aaltonen LA
Fam Cancer; 2012 Sep; 11(3):525-8. PubMed ID: 22638770
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 Gly587Arg variant is associated with differential enzymatic activity and risk of esophageal squamous-cell carcinoma.
Zhao D; Zhang X; Guo Y; Tan W; Lin D
Mol Carcinog; 2009 Oct; 48(10):934-41. PubMed ID: 19347867
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
17. Genetic variant of single-nucleotide polymorphism is associated with risk of esophageal squamous cell carcinoma.
Ye B; Feng J; Pan X; Yang Y; Ji C; Cheng M; Cheng Y; Shi J; Zhao H
Genet Test Mol Biomarkers; 2014 Jan; 18(1):45-9. PubMed ID: 24093763
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a familial esophageal cancer susceptibility gene on chromosome 13.
Hu N; Goldstein AM; Albert PS; Giffen C; Tang ZZ; Ding T; Taylor PR; Emmert-Buck MR
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1112-5. PubMed ID: 14578153
[TBL] [Abstract][Full Text] [Related]
19. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
20. Familial Esophageal Squamous Cell Carcinoma with damaging rare/germline mutations in KCNJ12/KCNJ18 and GPRIN2 genes.
Khalilipour N; Baranova A; Jebelli A; Heravi-Moussavi A; Bruskin S; Abbaszadegan MR
Cancer Genet; 2018 Feb; 221():46-52. PubMed ID: 29405996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
